These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9769023)

  • 21. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
    Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
    Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress and the pathogenesis of neurodegenerative disorders.
    Reynolds A; Laurie C; Mosley RL; Gendelman HE
    Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of complement in neurodegeneration and neuroinflammation.
    Bonifati DM; Kishore U
    Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases.
    Sabahi M; Joshaghanian A; Dolatshahi M; Jabbari P; Rahmani F; Rezaei N
    J Mol Neurosci; 2021 Jul; 71(7):1410-1424. PubMed ID: 33713321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interfering with the pathologic activation of microglial cells and astrocytes in dementia.
    Schubert P; Rudolphi K
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S21-8. PubMed ID: 9769026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glia and their cytokines in progression of neurodegeneration.
    Mrak RE; Griffin WS
    Neurobiol Aging; 2005 Mar; 26(3):349-54. PubMed ID: 15639313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [COX plays a pivotal role in the progressive neuronal loss in neurodegenerative diseases].
    Gao JP; Sun S; Li WW; Zhao H; Cai DF
    Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):214-20. PubMed ID: 18819488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
    Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW
    J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.
    McGeer EG; McGeer PL
    J Alzheimers Dis; 2010; 19(1):355-61. PubMed ID: 20061650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction.
    Badoer E
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1580-5. PubMed ID: 20638485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia.
    Banati RB; Gehrmann J; Kellner M; Holsboer F
    Clin Neuropathol; 1995; 14(4):197-200. PubMed ID: 8521621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between neuroinflammation and neurodegenerative diseases].
    Qiu AW; Liu Z; Guo J; Peng YP
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):353-8. PubMed ID: 22242402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic inflammation in Alzheimer's disease offers therapeutic opportunities.
    McGeer EG; McGeer PL
    Expert Rev Neurother; 2001 Sep; 1(1):53-60. PubMed ID: 19811046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.